Skip to main content

Peer Review reports

From: First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors

Original Submission
7 Nov 2023 Submitted Original manuscript
3 Dec 2023 Reviewed Reviewer Report
10 Dec 2023 Reviewed Reviewer Report
23 Dec 2023 Author responded Author comments - Jin Li
Resubmission - Version 2
23 Dec 2023 Submitted Manuscript version 2
23 Dec 2023 Author responded Author comments - Jin Li
Resubmission - Version 3
23 Dec 2023 Submitted Manuscript version 3
26 Feb 2024 Author responded Author comments - Jin Li
Resubmission - Version 4
26 Feb 2024 Submitted Manuscript version 4
26 Feb 2024 Author responded Author comments - Jin Li
Resubmission - Version 5
26 Feb 2024 Submitted Manuscript version 5
27 Feb 2024 Author responded Author comments - Jin Li
Resubmission - Version 6
27 Feb 2024 Submitted Manuscript version 6
27 Feb 2024 Author responded Author comments - Jin Li
Resubmission - Version 7
27 Feb 2024 Submitted Manuscript version 7
Publishing
2 Apr 2024 Editorially accepted
10 Apr 2024 Article published 10.1186/s12885-024-12216-7

You can find further information about peer review here.

Back to article page